Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase NA 1Phase 3 1

Status

Unknown 2Terminated 2Completed 1

Sponsor Class

OTHER 4INDUSTRY 1

Study Type

Interventional 4Observational 1

Sponsor

Cancer Type

Gastrointestinal 19Gynecologic 6Thoracic 5Head & Neck 5Breast 3Other solid neoplasm 1Dermatologic 1

Conditions

Carcinoma, Non-Small-Cell Lung 4Thymoma 1Thymic epithelial tumor 1Lung Neoplasms 1

Interventions

Carboplatin 1167Cisplatin 889Pemetrexed 845pembrolizumab 622Paclitaxel 608Docetaxel 539Gemcitabine 428Radiotherapy 390Erlotinib Hydrochloride 381Nivolumab 344Bevacizumab 337Etoposide 296durvalumab 264Drug Therapy 260osimertinib 236atezolizumab 224Radiosurgery 194Gefitinib 186Vinorelbine 149Magnetic Resonance Spectroscopy 131Ipilimumab 129130-nm albumin-bound paclitaxel 124Cetuximab 113Blood Specimen Collection 106anlotinib 105tislelizumab 103Topotecan 103Specimen Handling 102Surgical Procedures, Operative 101Cyclophosphamide 101

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
TP protocol × Thoracic × Clear all
NCT01393080 2016-02-17

NSCLC

Tianjin Medical University Cancer Institute and Hospital

Phase NA Unknown
160 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT00801736 2013-12-10

ET

University College, London

Phase 3 Terminated
648 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT01902875 2013-07-18

Preconditioning Chemotherapy Combination With Cytokine Induced Killer Cell (CIK) Immunotherapy

Jinling Hospital, China

Unknown
100 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT00818090 2013-04-12

Paclitaxel and Cisplatin for Thymic Neoplasm

Korean Cancer Study Group

Phase 2 Terminated
39 enrolled
Thoracic

Thymic epithelial tumor, Thymoma

NCT00680940 2012-08-07

NSCLC

Cadila Pharnmaceuticals

Phase 2 Completed
221 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon âš¡